Follow
Cyro von Zuben de Valega Negrão
Cyro von Zuben de Valega Negrão
Verified email at lnbio.cnpem.br
Title
Cited by
Cited by
Year
UV 254 nm is more efficient than UV 222 nm in inactivating SARS-CoV-2 present in human saliva
R Sesti-Costa, C von Zuben Negrão, JF Shimizu, A Nagai, RSN Tavares, ...
Photodiagnosis and Photodynamic Therapy 39, 103015, 2022
172022
High-throughput screening reveals new glutaminase inhibitor molecules
RK E. Costa, CT Rodrigues, JC H. Campos, LS Paradela, MM Dias, ...
ACS Pharmacology & Translational Science 4 (6), 1849-1866, 2021
52021
HER2 aptamer-conjugated iron oxide nanoparticles with PDMAEMA-b-PMPC coating for breast cancer cell identification
CZ de Valega Negrão, NN Cerize, A da Silva Justo-Junior, RB Liszbinski, ...
Nanomedicine (London, England), 2024
12024
Biological Sequences for Gene Silencing of Interest for Pest Control in Soybean Cultivation and Associated Methods and Use
H Marques Barbosa de Souza, GC Maktura, GV Guidelli, ...
BR Patent App. BR102024006442-9, 2024
2024
Machine Learning Model to Predict Allocation of Patients with Chronic Back Pain for Integrated Practice Units in a System of Value-based Health Care
VP Barbosa, JLM Said dos Reis, C von Zuben de Valega Negrão, ...
medRxiv, 2023.11. 05.23298111, 2023
2023
Discovery of aminothiazole derivatives as a chemical scaffold for glutaminase inhibition
RKE Costa, GA Brancaglion, MP Pinheiro, D Adamoski, BN da Silva, ...
Results in Chemistry 5, 100842, 2023
2023
The Descriptive and Analytical Epidemiology of Glioblastoma Worldwide: an Informative Science Review
CZ de Valega Negrao, JPM Telles, VM de Paula Guirado, LV Menezes, ...
OSF Preprints, 2023
2023
Iron Oxide Nanoparticles Coated with Biodegradable Block-Copolymer PDMAEMA-b-PMPC and Functionalized with Aptamer for HER2 Breast Cancer Cell Identification
CZ de Valega Negrao, NNP Cerize, AS Justo-Junior, RB Liszbinski, ...
bioRxiv, 2023.06. 06.543859, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–8